Certara, Inc. CERT

CERT Company Overview

Certara, Inc. is a global biosimulation and model-informed drug development (MIDD) company that provides software and technology-enabled services to pharmaceutical, biotechnology, and regulatory organizations. The company operates at the intersection of life sciences, data science, and regulatory science, helping clients improve decision-making across drug discovery, development, and regulatory approval. Certara’s offerings are used to simulate how drugs behave in the human body, optimize clinical trial design, and support regulatory submissions.

Founded in 2008 through the merger of Tripos International and Pharsight Corporation, Certara has evolved from specialized pharmacometrics software providers into an integrated platform company. Its business is driven primarily by recurring software subscriptions and long-term services engagements, supported by deep regulatory credibility, including frequent use of its tools in submissions to the U.S. Food and Drug Administration (FDA) and other global regulators. The company positions itself as a leader in MIDD, a methodology increasingly encouraged by regulatory agencies to improve efficiency and reduce development risk.